X-14690691-GTCTCTC-GTCTC

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP6_ModerateBS2_Supporting

The NM_002063.4(GLRA2):​c.931-4_931-3delTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00868 in 833,596 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00010 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.010 ( 0 hom. 2 hem. )

Consequence

GLRA2
NM_002063.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.180
Variant links:
Genes affected
GLRA2 (HGNC:4327): (glycine receptor alpha 2) The glycine receptor consists of two subunits, alpha and beta, and acts as a pentamer. The protein encoded by this gene is an alpha subunit and can bind strychnine. Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

BP6
Variant X-14690691-GTC-G is Benign according to our data. Variant chrX-14690691-GTC-G is described in ClinVar as [Benign]. Clinvar id is 2232252.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLRA2NM_002063.4 linkc.931-4_931-3delTC splice_region_variant, intron_variant Intron 7 of 8 ENST00000218075.9 NP_002054.1 P23416-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLRA2ENST00000218075.9 linkc.931-4_931-3delTC splice_region_variant, intron_variant Intron 7 of 8 1 NM_002063.4 ENSP00000218075.4 P23416-1

Frequencies

GnomAD3 genomes
AF:
0.0000917
AC:
10
AN:
109014
Hom.:
0
Cov.:
22
AF XY:
0.0000629
AC XY:
2
AN XY:
31804
show subpopulations
Gnomad AFR
AF:
0.0000671
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000588
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000191
Gnomad OTH
AF:
0.000692
GnomAD3 exomes
AF:
0.00321
AC:
399
AN:
124260
Hom.:
0
AF XY:
0.0000770
AC XY:
3
AN XY:
38956
show subpopulations
Gnomad AFR exome
AF:
0.000657
Gnomad AMR exome
AF:
0.00438
Gnomad ASJ exome
AF:
0.00642
Gnomad EAS exome
AF:
0.00215
Gnomad SAS exome
AF:
0.00226
Gnomad FIN exome
AF:
0.00416
Gnomad NFE exome
AF:
0.00320
Gnomad OTH exome
AF:
0.00410
GnomAD4 exome
AF:
0.00997
AC:
7223
AN:
724539
Hom.:
0
AF XY:
0.00000983
AC XY:
2
AN XY:
203377
show subpopulations
Gnomad4 AFR exome
AF:
0.00432
Gnomad4 AMR exome
AF:
0.00313
Gnomad4 ASJ exome
AF:
0.00692
Gnomad4 EAS exome
AF:
0.00268
Gnomad4 SAS exome
AF:
0.00510
Gnomad4 FIN exome
AF:
0.00365
Gnomad4 NFE exome
AF:
0.0117
Gnomad4 OTH exome
AF:
0.00796
GnomAD4 genome
AF:
0.000101
AC:
11
AN:
109057
Hom.:
0
Cov.:
22
AF XY:
0.0000628
AC XY:
2
AN XY:
31857
show subpopulations
Gnomad4 AFR
AF:
0.000100
Gnomad4 AMR
AF:
0.000588
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000191
Gnomad4 OTH
AF:
0.000683

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Mar 17, 2022
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752610633; hg19: chrX-14708813; API